Pharma firms may soon have the chance to use US prisoners in
clinical drug trials after a new report by a panel of medical
advisers at the Institute of Medicine recommended government laws
against the practice be loosened.
Covalent Group has signed a $1.7m (€1.3m) contract with a new,
undisclosed pharma firm to carry out a Phase II trial on a new drug
for atherosclerosis - a disease affecting the arterial blood
vessels throughout the body.
As global contract research spending remains robust, business is
booming for Pharmaceutical Product Development (PPD) as the US firm
reported a surge in sales, profits and new business for its second
Despite looming threats from cheap Asian competitors, European
contract research organisations (CROs) still have a fighting chance
in the global R&D outsourcing market, according to a report by
research analysts Frost & Sullivan.
Parexel has linked arms with Synchron to cement itself in India for
the first time - joining the growing number of contract research
organisations (CRO) that are being lured to the region through the
promise of cost savings.
As clinical trial activity in the Asia Pacific region continues to
boom, Novotech, the largest Australian owned contract research
organisation (CRO) has presented a checklist to help pharma firms
minimise risk when choosing a partner.